This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)
By Matthew Perrone
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
“Today’s approval addresses the great need for products to help reduce the impact of RSV disease on children, families and the health care system” said FDA's Dr. John Farley in a statement.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children. There are no vaccines for babies yet, though Pfizer and other companies are working on them.
AstraZeneca’s drug, to be sold under the brand name Beyfortus, is a laboratory-made version of an antibody that helps the immune system fight off RSV. Under the FDA approval, babies — including preterm infants — can receive a single injection to protect against their first season of RSV, which typically lasts about five months. Children up to age 2 can receive another dose to protect them during their second season facing the virus.
Beyfortus, which will be marketed in the U.S. by Sanofi, is already approved in Canada, Europe and the U.K. Sanofi did not immediately announce the U.S. price of the treatment.
FDA officials approved the drug based on three studies showing Beyfortus reduced the risk of RSV infection between 70% and 75% among infants and children 2 and younger.
Advisers to the Centers for Disease Control and Prevention will meet early next month to recommend exactly who should get the drug.
A similar antibody drug won FDA approval more than 20 years ago, but it’s only recommended for high-risk babies and requires monthly injections. Pediatricians say the drug is underutilized and they expect the longer-lasting effect of AstraZeneca's shot to improve uptake.
In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
After decades of setbacks for RSV research, drugmakers have made big strides this year, launching the first vaccines against the virus. In May, the FDA approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
William Li and Danielle Chang, co-founders of The Hao Life, join Cheddar Innovates to discuss how they're shaking up the $71 billion supplement industry by putting a modern spin on traditional natural Chinese remedies.
The Coca-Cola Company is teaming up with science education personality Bill Nye as part of its World Without Waste Initiative to describe the bottle-to-bottle plastic recycling process through a vividly animated, stop-motion short film. Christine Yeager, director of sustainability at The Coca-Cola Company, North America, joined Cheddar News to talk about their initiative and the partnership. "We really wanted to partner with someone who can help us make recycling relatable, but also has a very um respected voice in the climate change space," she said.
Catching you up on what you need to know on Apr 14, 2022, with the U.S. sending $800M to Ukraine, updates on the subway shooting in Brooklyn, Gov. Abbott putting a pause on his southern border truck inspections, migrants being bused from Texas to Washington, DC, the travel mask mandate extending until May 3, and more.
Energy costs continue to rise, our electrical grid is outdated, and the focus on renewable energy is more important than ever. One company says it has an answer: pods that store solar energy for long-term, 24-hour usage that can also function as mini power grids and charge electric vehicles. Azelio's TES.PODs store solar energy during the day, and hold it for use around the clock, providing a solution for charging electric vehicles, powering rural areas, and much more. Jonas Wallmander, CEO of Azelio, joins Closing Bell to discuss the company's solar energy storage technology, how it can be used to power communities and build out electric vehicle charging infrastructure, and more.
Catching you up with what you need to know on Apr 12, 2022, with Russia concentrating forces in eastern Ukraine, rising inflation, severe weather from Minnesota to the Gulf Coast, Philadelphia brings back its indoor mask mandate, PG&E pays $55 million for wildfire settlement, and more
Catching you up on what you need to know on April 11, 2022, with updates on the Russia-Ukraine War, France’s presidential election, the record deforestation of the Amazon Rainforest, retail giant Amazon's objection to the Staten Island union vote, the worsening baby formula shortage, a lawsuit against Rutgers Law School, and a stomach illness possibly linked to Lucky Charms cereal.
SpaceX launched its first all commercial-crew mission to the International Space Station on Friday. Cheddar News speaks with Jim Cantrell, CEO and President of Phantom Space Corporation why this launch is a big leap for space tourism.
Nautilus Labs closed $34 million in funding from investors including the Microsoft Climate Innovation Fund. The company plans to use its funding to improve shipping industry efficiency with its software. Nautilus CEO Matt Heider joined Cheddar News to talk about how it tackles the carbon emissions in the global supply chain. "We've seen on 10-day voyages saving $60,000 worth of fuel just by managing speed with greater confidence around the future. The environmental impact of that is also huge," he said. "Saving that amount of fuel is a kind of taking over 1000 cars off the road this year."
